Printer Friendly

Research and Markets: Global Glucose Monitoring Market Report: 2012 Edition Featuring The Key Players Johnson & Johnson, Abbott Lab, Roche, and Bayer AG.

DUBLIN -- Dublin - Research and Markets (http://www.researchandmarkets.com/research/f65e32bf/global_glucose_mon) has announced the addition of the "Global Glucose Monitoring Market Report: 2012 Edition" report to their offering.

The worldwide market for blood glucose monitoring is mainly dependent on the number of diabetes patients in the world which is growing significantly and is expected to grow even further in the near future. As a result, the worldwide market for glucose monitoring devices should also grow. There is no cure for diabetes and it can only be controlled. In order to control it, blood glucose monitoring is mandatory.

Diabetes can be of 2 types i.e. type I and type II. Type II diabetes is so far more prevalent compared to type I. The type I diabetes can be monitored with the help of regular glucose monitoring devices and self monitoring blood glucose monitoring devices. Regular glucose monitoring is done with the help of standard hand prick glucose monitors. This segment contributes the major share of total sales of blood glucose monitoring industry. The blood glucose test strips which are required for glucose tests are disposable which means there is a steady growth opportunity in this market.

Continuous glucose monitoring is mainly required for type I diabetes patients or patients with very high blood glucose level. A type I diabetes is less prevalent; the market for CGM (Continuous glucose monitoring) devices is smaller compared to Regular glucose monitoring market. CGM is a costlier procedure and is not covered automatically by medical insurances which also affect the sales of this particular segment. CGM is an invasive procedure and operation is required to place the sensor in the patient's body. As soon as the reimbursement of CGM improves, the perfomance of the market improve.

The global aging population, obese population, worldwide health expenditure and awareness about diabetes are the factors which are fuelling the growth of the glucose monitoring industry. The unwillingness of patients in frequent glucose test and increased competition in the developed market are the major challenges to the growth.

About This Report:

The report provides an analysis of the glucose monitoring market. It also discusses the major trends, growth drivers and challenges in the market. The regular glucose monitoring market is mainly controlled by four major players namely Roche, J&J-Lifescan, Bayer and Abbott whereas the CGM market is controlled by Medtronic and Dexcom.

Key Topics Covered:

- Glucose Monitoring

- Glucose Monitoring - Market Size

- Glucose Monitoring Market by Segments

- Key Trends

- Market Drivers

- Challenges

- Significant Developments

- Competitive Landscape

- Company Profiles

- Market Outlook

For more information visit http://www.researchandmarkets.com/research/f65e32bf/global_glucose_mon
COPYRIGHT 2012 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Article Type:Report
Date:Apr 4, 2012
Words:506
Previous Article:Research and Markets: Urological Disorders Therapeutics to 2017 - Large Number of Licensing Deals for Approved Products Reflects a Pessimistic R&D...
Next Article:Galtronics Launches High-Performance Outdoor DAS Antennas to Meet Growing Data Demands.
Topics:

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters